111 related articles for article (PubMed ID: 1851021)
21. [Chemotherapy of small-cell lung cancer by a combination of teniposide, ifosfamide and carboplatin].
Moro D; Orfeuvre H; Nagy-Mignotte H; Mousseau M; Blanc-Jouvan F; Schaerer R; Brambilla C
Bull Cancer; 1994 Jan; 81(1):38-42. PubMed ID: 7949582
[TBL] [Abstract][Full Text] [Related]
22. A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.
Bleehen NM; Girling DJ; Machin D; Stephens RJ
Br J Cancer; 1993 Dec; 68(6):1150-6. PubMed ID: 8260367
[TBL] [Abstract][Full Text] [Related]
23. Combination chemotherapy for small cell carcinoma of the lung: evaluation of four-drug combination of cyclophosphamide, vincristine, methotrexate, and procarbazine.
Ohnoshi T; Hiraki S; Nakata Y; Machida K; Fujii M; Nakata Y; Murakami N; Miyake K; Harada J; Ozawa S; Seto T; Tamura T; Kimura I
Acta Med Okayama; 1983 Apr; 37(2):147-53. PubMed ID: 6307001
[TBL] [Abstract][Full Text] [Related]
24. A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.
Bleehen NM; Girling DJ; Machin D; Stephens RJ
Br J Cancer; 1993 Dec; 68(6):1157-66. PubMed ID: 7505104
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
26. Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial.
Havemann K; Wolf M; Holle R; Gropp C; Drings P; Manke HG; Hans K; Schroeder M; Heim M; Victor N
Cancer; 1987 Mar; 59(6):1072-82. PubMed ID: 3028596
[TBL] [Abstract][Full Text] [Related]
27. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
Ettinger DS
Semin Oncol; 1995 Feb; 22(1 Suppl 2):23-7. PubMed ID: 7846538
[TBL] [Abstract][Full Text] [Related]
28. A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group.
Ettinger DS; Finkelstein DM; Abeloff MD; Ruckdeschel JC; Aisner SC; Eggleston JC
J Clin Oncol; 1990 Feb; 8(2):230-40. PubMed ID: 2153765
[TBL] [Abstract][Full Text] [Related]
29. Effects of intensive induction chemotherapy for extensive-disease small cell bronchogenic carcinoma in protected environment-prophylactic antibiotic units.
Valdivieso M; Cabanillas F; Keating M; Barkley HT; Murphy WK; Burgess MA; Frazier H; Chen T; Bodey GP
Am J Med; 1984 Mar; 76(3):405-12. PubMed ID: 6322584
[TBL] [Abstract][Full Text] [Related]
30. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Hatlevoll R; Dahle R; Boye N; Wang M; Vigander T; Vilsvik J; Skovlund E; Hannisdal E; Aamdal S;
J Clin Oncol; 2002 Dec; 20(24):4665-72. PubMed ID: 12488411
[TBL] [Abstract][Full Text] [Related]
31. Combination chemotherapy in small cell lung carcinoma. A randomized study of two intensive regimens.
Lowenbraun S; Birch R; Buchanan R; Krauss S; Durant J; Perez C; Mill W; Vollmer R; Ogden L
Cancer; 1984 Dec; 54(11):2344-50. PubMed ID: 6093979
[TBL] [Abstract][Full Text] [Related]
32. Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study.
Aisner J; Goutsou M; Maurer LH; Cooper R; Chahinian P; Carey R; Skarin A; Slawson R; Perry MC; Green MR
J Clin Oncol; 1992 Aug; 10(8):1230-6. PubMed ID: 1321892
[TBL] [Abstract][Full Text] [Related]
33. Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results.
Ardizzoni A; Fusco V; Pennucci C; Baldini E; Orsatti M; Vitale V; Bonavia M; Baracco F; Mereu C; Rosso R
Anticancer Res; 1991; 11(2):681-4. PubMed ID: 1648333
[TBL] [Abstract][Full Text] [Related]
34. A randomized study of radiation treatment in small cell bronchial carcinoma treated with two types of four-drug chemotherapy regimens.
Nõu E; Brodin O; Bergh J
Cancer; 1988 Sep; 62(6):1079-90. PubMed ID: 2457422
[TBL] [Abstract][Full Text] [Related]
35. Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer.
Arcangeli G; Righini R; Nervi C; Guerra A; Tirindelli D; Hopkins H; Looney W
Cancer Treat Rep; 1985 Jan; 69(1):25-31. PubMed ID: 2981618
[TBL] [Abstract][Full Text] [Related]
36. Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer.
Murray N; Shah A; Osoba D; Page R; Karsai H; Grafton C; Goddard K; Fairey R; Voss N
J Clin Oncol; 1991 Sep; 9(9):1632-8. PubMed ID: 1651995
[TBL] [Abstract][Full Text] [Related]
37. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
[TBL] [Abstract][Full Text] [Related]
38. Comparison of cyclophosphamide, doxorubicin, and vincristine with an alternating regimen of methotrexate, etoposide, and cisplatin/cyclophosphamide, doxorubicin, and vincristine in the treatment of extensive-disease small-cell lung carcinoma: a Mid-Atlantic Oncology Program study.
Wampler GL; Heim WJ; Ellison NM; Ahlgren JD; Fryer JG
J Clin Oncol; 1991 Aug; 9(8):1438-45. PubMed ID: 1649265
[TBL] [Abstract][Full Text] [Related]
39. Combination chemotherapy with vincristine, epirubicin and cyclophosphamide in small cell lung carcinoma. Polish Lung Cancer Cooperative Group.
Jassem J; Karnicka-Młodkowska H; Drozd-Lula M; Strug A; Pilarska-Machowicz A; Michalski A; Kowal E; Moś-Antkowiak R; Zych J
Eur J Cancer; 1992; 28(2-3):473-6. PubMed ID: 1317199
[TBL] [Abstract][Full Text] [Related]
40. Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group.
Hong WK; Nicaise C; Lawson R; Maroun JA; Comis R; Speer J; Luedke D; Hurtubise M; Lanzotti V; Goodlow J
J Clin Oncol; 1989 Apr; 7(4):450-6. PubMed ID: 2538577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
